<!doctype html>

<html lang="en">
<head>
    <meta charset="utf-8">
    <meta content="IE=edge" http-equiv="X-UA-Compatible">
    <meta content="width=device-width, initial-scale=1.0" name="viewport">
    <title>GA TB Reference Guide </title>
    <meta content="GA TB Reference Guide" name="description">
    <meta content="SitePoint" name="author">
    <link href="../assets/uikit.css" rel="stylesheet">
    <link href="../assets/style.css" rel="stylesheet">
</head>
<body>


<table>
    <tr>
        <td>CD4 count and/or clinical status at time of TB diagnosis</td>
        <td>ART Initiation</td>
    </tr>
    <tr>
        <td>< 50 cells/mm3**</td>
        <td>within 2 weeks of starting TB therapy.</td>
    </tr>
    <tr>
        <td>> 50 cells/mm3**</td>
        <td>by 8 to 12 weeks of starting TB therapy</td>
    </tr>
    <tr>
        <td>Pregnant, any CD4 count</td>
        <td>As early as feasible</td>
    </tr>
</table>

<p>** EXCEPTION: tuberculous meningitis. To avoid life-threatening CNS immune reconstitution inflammatory syndrome
    (IRIS), persons living with HIV and tuberculous meningitis should not be started on ART until AFTER 8 weeks of TB
    therapy</p>

<p>Above based on guidelines developed by the Department of Health and Human Services (DHHS) Panel on Guidelines for Use
    of Antiretroviral Agents for Adults and Adolescents and Use of Antiretroviral Drugs in Pregnant Women with HIV
    Infection and Interventions to Reduce Perinatal Transmission in the United States, last reviewed and updated April
    15, 2019 (<a href="https://aidsinfo.nih.gov/guidelines">https://aidsinfo.nih.gov/guidelines</a>).</p>


</body>
<script src="../assets/uikit.js" type="text/javascript"></script>
<script src="../assets/uikit-icons.js" type="text/javascript"></script>
</html>
